We have published a wealth of information on Australian health and medical research, and on specific issues relating to Australian health and health care. These include statements, strategies, guidelines and other reports – all of which are publicly available.
Read our latest resources
NHMRC seeks to maximise the reporting of impacts arising from the research that it funds and from its other activities, but it cannot undertake this impact reporting on its own.
The George Institute for Global Health has developed the SMARThealth system, a low cost digital platform that supports clinical decision-making and improves the screening, detection and management of adults with chronic diseases. It uses guideline and evidence-based algorithms developed over 15 years of research and development and can be adapted for low and middle income countries.
The purpose of these procedures is to promote the integrity and accountability of the National Health and Medical Research Council (NHMRC).
The NHMRC Research Integrity and Misconduct Policy clarifies the role and responsibilities of NHMRC Administering Institutions about notifying NHMRC of research integrity matters and describes how NHMRC responds to such matters.
Globally, more than one billion people suffer from high blood pressure. The George Institute for Global Health (TGI) has trialled a new low-dose pill for hypertension that combines three medications in one (Triple Pill), which could change the way high blood pressure is treated around the world.
Pharmaxis Ltd is an Australian pharmaceutical research company established in 1998. It listed on the Australian Securities Exchange (ASX) in 2003. The business focuses on new therapies to treat inflammation and fibrosis with a portfolio of products at various stages of development and approval. With origins in clinical research, this Australian-owned start up successfully competes in an international market.
Mannitol is a naturally occurring sugar alcohol from the sap of the manna ash tree that can be produced as a dry powder. In the 1990s, Dr Sandra Anderson and colleagues at Sydney's Royal Prince Alfred Hospital (RPAH) began research into how inhaled mannitol can be used to diagnose asthma. This work resulted in the development of two new pharmaceutical products, Aridol® and Bronchitol®.
Picato® is a prescription gel that treats skin actinic keratosis (potentially pre-cancerous sunspots). The journey to develop this product began in the 1970s when Queensland researcher, Jim Aylward, became interested in a local farming story about the healing properties of the sap of the radium weed Euphorbia peplus (E. peplus) when applied to sunspots on the skin.
NHMRC refuses to tolerate fraud and has a commitment to high ethical, moral and legal standards. A key focus of this framework is to raise awareness of fraud among NHMRC staff and other people who deal with NHMRC, to assist in the prevention, detection and reporting of suspected fraud.
Ethical conduct in research with Aboriginal and Torres Strait Islander Peoples and communities: Guidelines for researchers and stakeholders provides a set of principles to ensure research is safe, respectful, responsible, high quality and of benefit to Aboriginal and Torres Strait Islander people and communities.
Keeping research on track II was developed to provide advice on how the values and principles outlined in Ethical conduct in research with Aboriginal and Torres Strait Islander Peoples and communities: Guidelines for researchers and stakeholders can be put into practice in research.
The Grant Review Panel videos will be updated shortly for the 2019 Ideas Grants peer review process.
A guide for researchers when considering self-nominating for peer review panels. This covers the different scheme types and what level of expertise and experience are required.
NHMRC’s Health Innovation Advisory Committee has been appointed to provide advice on current and emerging issues related to the development, commercialisation and uptake of innovative technologies and practices arising from health and medical research.
Our rescinded guidelines are stored for historical purposes on the Australian Government Web Archive (AGWA). Below are the links to many of these. This list may not be fully comprehensive but is current at December 2017.
A guide for peer reviewers when evaluating industry-relevant skills, experience and achievements in its assessment of applicants’ track records.
The purpose of this guideline is to provide a framework for candidates considering undertaking a sabbatical at NHMRC, and for NHMRC delegates considering such applications.
Promoting social and emotional development and wellbeing of infants in pregnancy and the first year of life
This report Promoting social and emotional development and wellbeing of infants in pregnancy and the first year of life: a NHMRC report on the evidence summarises findings of the evaluation of evidence on the effectiveness of interventions delivered in pregnancy or the first postpartum year.
The Assigners Academy provides independent expert advice to the CEO on matters relating to the administration of NHMRC’s peer review process.
In providing a safe and healthy workplace, we provide an environment in which we can all effectively contribute to achieving community and business outcomes.
This page details the information required when seeking a grantee variation under the Grantee Variations Policy and also explains the NHMRC variation process.
This document provides advice to researchers and Research Administration Officers (RAOs) about the factors that NHMRC considers when deciding whether to approve or reject a variation request under the Grantee Variations Policy.
The Grantee Variation Policy describes our policy position on requests for varying grants.
When working with research that involves human embryos created by assisted reproductive technology (ART), it can be difficult to determine if a licence is required for training and quality assurance activities. The attached documents provide information and helpful links to help identify legislative requirements.
The Broad Research Area, Field of Research, Research Keywords/Phrases and Socio-Economic Objectives used by the NHMRC have been developed by the Australian Bureau of Statistics and published as the Australian and New Zealand Standard Research Classification 2008 edition.
Administering Institutions are required to submit, via RGMS, an Institutional Annual Compliance Report (IACR) to NHMRC each year detailing compliance with the NHMRC Funding Agreement and other relevant policies for the previous calendar year.
The Research Grant Management System (RGMS) training program aims to support researchers and administering institutions use the program. Training is structured around each stage of the NHMRC grant process, and covers the application, assessment, grant selection and monitoring stages.
The functions of the Commissioner are to investigate complaints regarding action/s by the Chief Executive Officer of the NHMRC or NHMRC Research Committee in relation to a funding application.
The health and medical research community was invited to comment on NHMRC’s Fellowship schemes with this document presenting the summary report from that consultation.
Our commitment to improving the health of Aboriginal and Torres Strait Islander peoples covers all aspects of NHMRC’s responsibilities, as well as contributing to the Australian Government’s Close the Gap initiatives.
This guide outlines the overarching principles and obligations under which NHMRC’s peer review process operates. This guide includes information about the standards and best practice for the conduct of peer review, obligations in accordance with legislation, and guidance on conflicts of interest in NHMRC peer review.
The NHMRC Open Access Policy is consistent with the Australian Government’s commitment to open access, open data and intellectual property (IP) management.
The information provided on this site is to assist you in understanding Intellectual Property (IP), including patents, engaging with industry and end users, and undertaking commercialisation activities.
Core principles have been developed to be used to determine whether particular expenses are DRCs for the NHMRC funded research activity in question.
At NHMRC, we aim to create a workplace which supports all staff, regardless of their gender, age, cultural/religious background, sexual orientation or personal attributes. We want NHMRC to be a flexible and fair work environment, in which staff can flourish and where differences between employees are respected and viewed as an organisational asset.
Electronic cigarettes are often marketed as a method to assist smokers to quit, or as a ‘safe alternative’ to conventional tobacco cigarettes. There is currently insufficient evidence to support these claims. This statement explains the current evidence, to assist consumers and policy-makers.
This plan identifies the workforce capability required by NHMRC to meet its objectives, now and into the future.
This policy clarifies the role and responsibilities of NHMRC Administering Institutions about notifying NHMRC of research integrity matters and describes how NHMRC responds to such matters.
Human Research Ethics Committees (HRECs) registered with NHMRC are required to submit annual reports regarding their activities. This Report on the Activity outlines what is required in the reports as well as details about the HRECs registered in Australia.
The October 2015 version of the January 2014 Funding Agreement and summary of changes. This version follows consultation with the research community.
The National principles of Intellectual Property management for publicly funded research provides guidance for the ownership, promotion, dissemination, exploitation and, where appropriate, protection of Intellectual Property generated through Australian Government funded research by public sector institutions.
This document covers the vision and mission statements of NHMRC to improve the health of Australians using exceptional, ethical research.
The strategic plan focuses on stronger integration across research, advice, ethics and regulation to further our goal. Seven key objectives and their strategies and measures are detailed here.
NHMRC sought a review of legal and policy barriers in Australia to promote a competitive and accessible clinical trials sector.
This review details current indemnity and insurance arrangements concerning clinical trials across the public and private sectors.
Quality assurance (QA) and evaluation are important to ensure effective work and the best outcomes. However, confusion arises over if an activity is research, evaluation or QA as there may be similar research methods used.
This document assists organisations in developing QA policy and appropriate oversight.
Despite the use of lead being reduced in many industries, it is still found in many environments and is known to have adverse effects on human health.
This report evaluates the evidence relating to individual level lead exposure in Australia, the effects from this and the effectiveness of intervention strategies.
There are concerns about the increasing availability of health-related genetic testing kits. This guide is for health professionals whose patients are considering buying a test kit or want to discuss their results.
Epigenetics has recently become a popular explanation for complex diseases of unknown origin. Epigenetics is the study of mechanisms that control how genes are switched ‘on’ and ‘off’ without any changes in the actual DNA of the cells.
The National Health and Medical Research Council (NHMRC) has developed Stem Cell Treatments – A Quick Guide for Medical Practitioners to assist practitioners in discussing stem cell treatments with their patients, and the risks involved in undergoing unproven treatments.
The Quick Guide is supported by the companion document Stem Cell Treatments – Frequently Asked Questions, which provides information for patients about stem cell treatments.
These resources provide information about the regulation of stem cell treatments in Australia that is no longer current. While correct at the time of publication (2013), this information does not reflect changes to the Australian Biologicals Regulatory Framework that came into force from 1 July 2018. Advice will be sought from NHMRC’s Council regarding the future of these documents early in the 2018-21 triennium.
The National Health and Medical Research Council (NHMRC) has developed the document Stem Cell Treatments – Frequently Asked Questions to provide consumers with information about stem cell treatments, and the risks involved in undergoing unproven treatments.
The Council of NHMRC endorsed the Principles of Peer Review (the Principles) at its 14 March 2013 meeting.